期刊文献+

醋酸钙对克拉玛依市少数民族血液透析患者高磷血症治疗的疗效观察

Observation of curative effect of calcium acetate tablets on Karamay minority hemodialysis patients with hyperphosphatemia
下载PDF
导出
摘要 目的观察使用醋酸钙片治疗克拉玛依市少数民族血液透析患者高磷血症的疗效。方法 70例规律血液透析的少数民族患者口服醋酸钙片治疗,观察治疗8周后矫正血钙、磷及血全段甲状旁腺激素变化。结果与治疗前相比,治疗后患者血磷水平下降,而矫正血钙和血全段甲状旁腺激素未见明显下降。结论醋酸钙片对克拉玛依市少数民族规律血液透析患者的高磷血症治疗有效。 Objective To observe the effect of calcium acetate tablets on treating hyperhosphataemia in Karamay minority patients during hemodialysis. Methods 70 hyperphosphatemic patients, who were minorities in Karamay and were treated with hemodialysis, were given calcium acetate tablets for 8 weeks. Serum phosphate, corrected serum calcium, and serum intact parathyroid hormone levels were determined before and after the treatment. Resdts Serum phosphate level decreased significantly, whereas corrected serum calcium and serum intact parathyroid hormone levels did not change significantly. Conclusion Calcium acetate tablets was effective in reducing phosphate in hyperphosphatemic minority patients having hemodialysis in Karamay."
出处 《新疆医学》 2017年第4期407-408,411,共3页 Xinjiang Medical Journal
关键词 醋酸钙片 血液透析 高磷血症 Calcium Acetate Tablets Hemodialysis Hyperphosphatemia
  • 相关文献

参考文献12

二级参考文献195

  • 1孙鲁英,左力,王梅.不同钙离子浓度透析液对血液透析患者钙平衡及甲状旁腺素的影响[J].中华肾脏病杂志,2004,20(3):210-213. 被引量:51
  • 2张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 3赵蕾,王坤,郭艳英,敖由特,徐翀,宋涛,格尔莉,沙根得克.耶里节夫,何秉贤.新疆博尔塔拉蒙古自治州蒙、哈、维、汉4民族30岁以上高血压及部分有关危险因素调查[J].高血压杂志,2006,14(3):214-218. 被引量:70
  • 4Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 5Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 6Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 7Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 8Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 9Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 10Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.

共引文献520

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部